Clinical Trial Update: The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance [NA]

View source ↗

Summary

The PRECISION Study is evaluating three fractions of prostate SBRT using RayPilot HypoCath image guidance for prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Risk Prostate Cancer
• Localized Prostate Cancer
• Low Risk Prostate Cancer

Snippet

Sponsor: NHS Lothian | Conditions: Localized Prostate Cancer, Low Risk Prostate Cancer | NA | Status: RECRUITING